Names and pronunciation
(koh-pan′-lih-sib) Aliqopa
PDF page 321
Loading InternPractice…
Drug reference
(koh-pan′-lih-sib) Aliqopa
PDF page 321
Func. class.: Antineoplastic biologic response modifiers
PDF page 321
USES: For the treatment of non- Hodgkin’s lymphoma
PDF page 321
CONTRAINDICATIONS: Preg- nancy, hypersensitivity Precautions: Breastfeeding, contracep- tion requirements, children, diabetes mellitus, diarrhea, geriatric patients, hepatic/pulmonary disease, hyperglyce- mia, hypertension, infertility, male-medi- ated teratogenicity, neutropenia, pneu- monitis, bone marrow suppression, infection, reproductive risk, serious rash, thrombocytopenia
PDF page 321
DOSAGE AND ROUTES Relapsed follicular lymphoma • Adult: IV 60 mg over 1 hr on days 1, 8, and 15 repeated q28days until disease progression; reduce dose to 45 mg if using with strong CYP3A4 inhibitor
PDF page 321
Available forms: Injection, lyophilized 60-mg single-dose vials
PDF page 321
• Adult: IV 60 mg over 1 hr on days 1, 8, and 15 repeated q28days until disease progression; reduce dose to 45 mg if using with strong CYP3A4 inhibitor
PDF page 321